ARCH VENTURE FUND X, L.P. - PRIME MEDICINE, INC. -- SCH 13G

Company

Prime Medicine, Inc.

Filed

February 13, 2023

Accession Number

0001072613-23-000104

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →